)
Paysign (PAYS) investor relations material
Paysign Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Q3 2026 revenue reached a record $30.80M, up 42.6% YoY; patient affordability growth lifted margins and earnings.
9M revenue grew 46.9% to $87.1M and net income rose to $18.9M from $6.2M.
FY26 revenue guidance remained $114M–$117M while profitability guidance increased; a planned 113-center plasma transition is expected to weigh on Q4 and 2027 results.
Financial highlights
Q3 gross profit was $19.92M, up 63.9% YoY; operating income rose to $7.32M from $1.58M and diluted EPS was $0.11 versus $0.04.
GAAP net income increased to $6.74M from $2.22M; Adjusted EBITDA rose 118% to $10.98M from $5M.
9M gross profit increased 57.4% to $56.0M and operating income rose to $21.0M from $5.5M; adjusted 9M EBITDA was $31.2M versus $14.5M.
Q3 operating expenses increased 19.2% to $12.60M; SG&A rose 22.8% to $10.29M, including $1.4M of stock-based compensation.
Outlook and guidance
FY26 revenue outlook remained $114M–$117M; gross margin guidance was 63.5%–64.5%, GAAP net income $23M–$24M, diluted EPS $0.37–$0.38 and Adjusted EBITDA $38.5M–$40M.
Year-end targets are 190–195 active patient affordability programs and 445–450 plasma centers; management expects 59–64 program additions in 2026.
Patient affordability growth and planned launches are expected to sustain growth into 2027; the 113-center transition is expected to reduce Q4 revenue by $1.5M and gross profit by $700K.
FY26 tax rate was expected at 21.3%; forecasted revenue and cash flows supported expected liquidity for at least 24 months, through Q3 2028.
- Double-digit growth in plasma payments and pharma co-pay, with expanding margins and market share.PAYS
17th Annual Midwest IDEAS Conference - Record revenue and margin expansion driven by dual growth engines and proprietary technology.PAYS
Investor presentation - Achieved 40.5% revenue growth and 107% EBITDA growth, with balanced dual-engine expansion.PAYS
Corporate presentation - Record revenue, margin expansion, and raised outlook driven by pharma and plasma growth.PAYS
Q2 2026 - FY2025 revenue up 40.5% to $82M; FY2026 guidance $106.5M–$110.5M, balanced by plasma and pharma.PAYS
Planet MicroCap Las Vegas 2026 - FY2025 saw 40.5% revenue growth and a shift to balanced plasma and pharma revenue streams.PAYS
16th Annual East Coast IDEAS Conference - FY2025 saw 40.5% revenue growth and expanding margins, with balanced plasma and pharma momentum.PAYS
Conference presentation - Revenue up 50.8% and net income more than doubled, with strong margin expansion in Q1 2026.PAYS
Q1 2026 - Annual meeting to elect seven directors and ratify auditor set for May 8, 2026.PAYS
Proxy filing
Next Paysign earnings date
Next Paysign earnings date
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
)
)